Indications and uses
temporarily shrinks hemorrhoidal tissue temporarily relieves itching, burning and discomfort associated with hemorrhoids
Anesthetic Hemorrhoidal
- Manufacturer
- Personal Care Products, Inc. | Anicare Pharmaceuticals Pvt. Ltd.
- Effective date
- 2020-07-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:22:31
Label at a glance#
ProductAnesthetic Hemorrhoidal With Aloe
Active ingredientPRAMOXINE HYDROCHLORIDE, ZINC OXIDE
Label structure9 sections
Dosage and administration
Direction for adults when practical, cleanse the affected area by patting or blotting with an appropriate cleansing tissue. Gently dry by patting or blotting with toilet tissue or soft cloth before application of this ointment, apply to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement Children under 12 years or age, ask a doctor.
Label contents#
Full prescribing information#
Drug Facts Active Ingredient
Pramoxine HCL 1%
Zinc oxide 12.5%
Purpose
Local anesthetic
Protectant
Keep out of reach of children
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Uses
temporarily shrinks hemorrhoidal tissue
temporarily relieves itching, burning and discomfort associated with hemorrhoids
Warnings
For external use only
Ask a doctor before use if you have - heart disease, high blood pressure, thyroid disease, diabetes, difficulty in urination due to enlargement of the prostate gland
Ask a doctor or pharmacist before use, if you are presently taking a prescription drug for high blood pressure or depression
When using this product - do not exceed the recommended daily dosage unless directed by a doctor, do not use this product with an applicator, if the applicator into the rectum causes additional pain. Consult a doctor promptly.
Stop use and ask a doctor if - you experience bleeding, condition worsens or does not improve within 7 days, these may be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Directions
Direction for adults
when practical, cleanse the affected area by patting or blotting with an appropriate cleansing tissue. Gently dry by patting or blotting with toilet tissue or soft cloth before application of this ointment, apply to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement
Children under 12 years or age, ask a doctor.
Other information
store between 59° and 86° F (15° and 30° C), close cap tightly after use, do not use if seal on tube is punctured or missing
Inactive ingredients
balsam peru, benzyl benzoate, calcium phohsphate, cocoa butter, glyceryl monostearate, glyceryl monoleate, kaolin, mineral oil, Aloe vera extract
Product Label
DRUGSTORE - Rx
SMART WELLNESS
Anesthetic Hemorrhoidal Ointment With Aloe
Quick and soothing, pain relief from burning, itching and discomfort
Shrinks swollen hemorrhoidal tissue
NET WT. 1.5 OZ. (42 g)
DRUGSTORE-Rx
SMART WELLNESS delivers outstanding quality in healthcare products, at truly amazing prices. We employ the highest standard when searching the world to bring the best value to your doorstep. Use our products confidently, knowing that attention and care has gone into every item That's smart wellness!
Distributed by: PERSONAL CARE PRODUCTS, LLC
Troy, Michigan 484084 U.S.A. Code No.MH/DRUGS/KD-313 Made in India
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1294330 | pramoxine HCl 1 % / zinc oxide 12.5 % Topical Ointment | PSN | 2 |
| 1294330 | pramoxine hydrochloride 0.01 MG/MG / zinc oxide 0.125 MG/MG Topical Ointment | SCD | 2 |
| 1294330 | Pramoxine hydrochloride 0.01 MG/MG / ZNO 0.125 MG/MG Topical Ointment | SY | 2 |
| 1294330 | pramoxine hydrochloride 1 % / zinc oxide 12.5 % Topical Ointment | SY | 2 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8 | Product name | 1 | 20140508 |
| a7051cba-790b-a699-81f8-dbbbdbd9b5ac | Product name | 1 | 20140508 |
| da108d9e-edc8-17a3-8c28-3251c6a8accc | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 29500-2438-1 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-1318-f424-e053-dadaa90a57ce | a0e3b500-1295-47cd-ab4e-503f51895bbb |
| 29500-2438-1 | 2020-07-24 | C162847 | 48780-1 | 9d75b9d0-1318-f424-e053-dadaa90a57ce | a0e3b500-1295-47cd-ab4e-503f51895bbb |
| 29500-2438-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1318-f424-e053-dadaa90a57ce | a0e3b500-1295-47cd-ab4e-503f51895bbb |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 29500-2438-1 | Anesthetic HemorrhoidalWith Aloe | 42 g in 1 TUBE | OINTMENT | 42 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 29500-2438 | ANESTHETIC HEMORRHOIDAL WITH ALOE (PRAMOXINE HYDROCHLORIDE, ZINC OXIDE) OINTMENT [PERSONAL CARE PRODUCTS, INC.] | 2 | Legacy NDC, 1 package rows | 20200725_a0e3b500-1295-47cd-ab4e-503f51895bbb.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PRAMOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 88AYB867L5 | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| PRAMOXINE | ACTIVE MOIETY | 068X84E056 | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| BALSAM PERU | INACTIVE INGREDIENT | 8P5F881OCY | 1 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 1 | |
| CALCIUM PHOSPHATE | INACTIVE INGREDIENT | 97Z1WI3NDX | 1 | |
| COCOA BUTTER | INACTIVE INGREDIENT | 512OYT1CRR | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| GLYCERYL OLEATE | INACTIVE INGREDIENT | 4PC054V79P | 1 | |
| KAOLIN | INACTIVE INGREDIENT | 24H4NWX5CO | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 1 |
Products#
Every source-derived product name is available through these pages.
- Anesthetic Hemorrhoidal With Aloe
- PRAMOXINE HYDROCHLORIDE, ZINC OXIDE
- BALSAM PERU
- BENZYL BENZOATE
- CALCIUM PHOSPHATE
- COCOA BUTTER
- GLYCERYL MONOSTEARATE
- KAOLIN
- MINERAL OIL
- GLYCERYL OLEATE
- PRAMOXINE HYDROCHLORIDE
- PRAMOXINE
- ZINC OXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 29500-2438 | 29500-2438-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BALSAM PERU | 8P5F881OCY | IACT |
| BENZYL BENZOATE | N863NB338G | IACT |
| CALCIUM PHOSPHATE | 97Z1WI3NDX | IACT |
| COCOA BUTTER | 512OYT1CRR | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| KAOLIN | 24H4NWX5CO | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| GLYCERYL OLEATE | 4PC054V79P | IACT |
| PRAMOXINE HYDROCHLORIDE | 88AYB867L5 | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | CAPSULE / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| GLYCERYL OLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | SOLUTION / INTRAMUSCULAR | 447 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 234 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, EXTENDED RELEASE / ORAL | 32.4 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | CAPSULE, EXTENDED RELEASE / ORAL | 21 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| GLYCERYL OLEATE | GLYCERYL OLEATE | 4PC054V79P | SPRAY / TOPICAL | 0.95 %w/w | ||
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET, COATED / ORAL | 93.6 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | TABLET, EXTENDED RELEASE / ORAL | 66 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| GLYCERYL OLEATE | GLYCERYL OLEATE | 4PC054V79P | GEL / TOPICAL | 1 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| COCOA BUTTER | COCOA BUTTER | 512OYT1CRR | SUPPOSITORY / RECTAL | 2280 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUPPOSITORY / RECTAL | 35 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | EMULSION / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | POWDER, FOR SUSPENSION / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | GRANULE, FOR SUSPENSION / ORAL | 4 mg | ||
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | PASTE, DENTIFRICE / DENTAL | 45.93 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | POWDER / TOPICAL | 10056 mg | ||
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET, FILM COATED / ORAL | 858 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | TABLET, COATED / ORAL | 52.44 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | TABLET / ORAL | 150 mg | ||
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | POWDER, DENTIFRICE / DENTAL | 0.11 mg/mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | SYRUP / ORAL | 10 mg/1ml | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET, EXTENDED RELEASE / ORAL | 352.63 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | TABLET, DELAYED RELEASE / ORAL | 18.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / TOPICAL | 836 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | INJECTION, SOLUTION / INTRAMUSCULAR | 750 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET / ORAL | 183.94 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| GLYCERYL OLEATE | GLYCERYL OLEATE | 4PC054V79P | POWDER, FOR SUSPENSION / ORAL | NA | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 23 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ab1ce5cf-f5ca-05f4-e053-2995a90ae8ba | a0e3b500-1295-47cd-ab4e-503f51895bbb | 2020-07-23 | Warnings | ab1ce5cf-f5ca-05f4-e053-2995a90ae8ba a0e3b500-1295-47cd-ab4e-503f51895bbb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.